Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.33 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.33 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.33 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.33 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4F8 | P98187 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL357701 | 0.89 | CYP11B1 (0.40) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL7468946 | 0.88 | CYP11B1 (0.42) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL11466692 | 0.88 | MCL1 (0.37) | ALDH1A1 | |
| SCHEMBL17514933 | 0.88 | CYP1A1 (0.53) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL3143778 | 0.86 | PDGFRB (0.37) | CYP3A4 | |
| SCHEMBL27791379 | 0.86 | MAPK1 (0.35) | CYP3A4ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL6191317 | 0.86 | ABCB1 (0.35) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL9180621 | 0.84 | ACHE (0.42) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL3144056 | 0.84 | PDGFRB (0.41) | CYP3A4 | |
| SCHEMBL27589325 | 0.84 | CYP3A4 (0.50) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0912563-B1 | CINCHONAN BASED CHIRAL SELECTORS FOR SEPARATION OF STEREOISOMERS | LINDNER WOLFGANG PROF DR (AT) | 2004-02-18 | — | — | EP | claimed |
| US-6313247-B1 | Cinchonan based chiral selectors for separation of stereoisomers | LINDNER WOLFGANG (AT) | 2001-11-06 | — | — | US | claimed |
| EP-0912563-A1 | CINCHONAN BASED CHIRAL SELECTORS FOR SEPARATION OF STEREOISOMERS | Lindner, Wolfgang, Prof. Dr. (AT) | 1999-05-06 | — | — | EP | claimed |
| WO-1997046557-A1 | CINCHONAN BASED CHIRAL SELECTORS FOR SEPARATION OF STEREOISOMERS | LINDNER WOLFGANG (AT) | 1997-12-11 | — | — | WO | claimed |
| US-20230017427-A1 | RESIN COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, AND INSULATED ELECTRICAL WIRE | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| WO-2021132631-A1 | THERMALLY CURABLE HARDCOAT AGENT, LAYERED FILM, AND DECORATED MOLDED OBJECT | 東洋インキＳＣホールディングス株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-7388100-B2 | Tertiary amine compounds | NISHIO TETSUYA | 2008-06-17 | — | — | US | disclosed |
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | NISHIO TETSUYA | 2006-07-06 | — | — | US | disclosed |
| US-6936189-B2 | Cyclic tertiary amine compound and organic electroluminescent device containing the compound | CHISSO CORPORATION (JP) | 2005-08-30 | — | — | US | disclosed |
| US-20040170866-A1 | Cyclic tertiary amine compound and organic electroluminescent device containing the compound | GUOFANG WANG (JP) | 2004-09-02 | — | — | US | disclosed |
| US-20020058155-A1 | Cyclic tertiary amine compound and organic electroluminescent device containing the compound | CHISSO CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| US-5352719-A | Blended with synthetic or natural polymers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1994-10-04 | — | — | US | disclosed |
| US-5116976-A | HINDERED AMINE LIGHT STABILIZER HYDRAZIDES | ATOCHEM NORTH AMERICA, INC (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0467344-A1 | Hindered amine light stabilizer hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-01-22 | — | — | EP | disclosed |
| US-5070170-A | Wettable, rigid gas permeable, substantially non-swellable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof | CIBA-GEIGY CORPORATION (US) | 1991-12-03 | — | — | US | disclosed |
| US-5070169-A | ACRYLATED RESIN, TOLUENE DIISOCYANATE LINKER | CIBA-GEIGY CORPORATION (US) | 1991-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058155-A1 | Cyclic tertiary amine compound and organic electroluminescent device containing the compound | AOC2, AOC3, CCNL2 | CYP3A4 3400/4885CYP1A1 1715/4885CYP1A2 2112/4885 |
| US-20040170866-A1 | Cyclic tertiary amine compound and organic electroluminescent device containing the compound | AOC2, AOC3, CCNL2 | CYP3A4 3400/4885CYP1A1 1715/4885CYP1A2 2112/4885 |
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | PIEZO1, YES1, SAT1 | CYP3A4 3797/4885CYP1A1 2605/4885CYP1A2 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.